CymitQuimica logo

CAS 116209-55-3

:

Levobetaxolol HCL

Description:
Levobetaxolol hydrochloride is a selective beta-1 adrenergic antagonist primarily used in the treatment of glaucoma and ocular hypertension. As a member of the beta-blocker class, it works by reducing intraocular pressure through decreased aqueous humor production. The substance is characterized by its high selectivity for beta-1 receptors, which minimizes potential side effects associated with non-selective beta-blockers. Levobetaxolol is typically administered as an eye drop solution, and its pharmacokinetics involve rapid absorption and a relatively short half-life, necessitating multiple daily doses for effective management of eye pressure. The hydrochloride salt form enhances its solubility and stability in aqueous solutions, making it suitable for ophthalmic formulations. Common side effects may include ocular discomfort, dry eyes, or transient blurred vision, while systemic absorption can lead to cardiovascular effects, although these are less common due to its localized application. Overall, Levobetaxolol hydrochloride is an important therapeutic agent in ophthalmology, providing an effective option for patients with elevated intraocular pressure.
Formula:C18H30ClNO3
InChI:InChI=1/C18H29NO3.ClH/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16;/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3;1H/t17-;/m0./s1
SMILES:CC(C)NC[C@@H](COc1ccc(cc1)CCOCC1CC1)O.Cl
Synonyms:
  • 2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, hydrochloride, (2S)-
  • 2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, hydrochloride, (S)-
  • Al 1577A
  • Betaxon
  • Levobetaxolol hydrochloride
  • (2S)-1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-(propan-2-ylamino)propan-2-ol hydrochloride (1:1)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.